4//SEC Filing
Plooster Matthew R 4
Accession 0001437749-23-006280
CIK 0001434647other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 7:59 AM ET
Size
6.3 KB
Accession
0001437749-23-006280
Insider Transaction Report
Form 4
Plooster Matthew R
Director
Transactions
- Purchase
Common Stock
2023-03-09$4.20/sh+11,000$46,148→ 18,500 total
Holdings
- 1,532
Common Stock
- 69(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Held jointly with spouse.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.1166 to $4.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001638364
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 7:59 AM ET
- Size
- 6.3 KB